Ex vivo spontaneous proliferation of PBMCs from ATLL and HAM/TSP was inhibited using a selective inhibitor of Jak3, which blocks signaling mediated by IL2, IL9 and IL15 [108]. This evidence concerns the gene IL2 and adult T-cell leukemia/lymphoma.